International cooperation to address and counter the world drug problem A/RES/73/192 in the International Standards for the Treatment of Drug Use Disorders, that reflect respect for human rights and dignity, including the right to enjoy the highest attainable standard of physical and mental health and well-being, promoting, as appropriate, within national and regional contexts, non-stigmatizing attitudes in the development and implementation of scientific evidence-based policies; 26. Also encourages Member States to promote the inclusion in national drug policies, in accordance with national legislation and as appropriate, of elements for the prevention and treatment of drug overdose, in particular opioid overdose, including the use of opioid receptor antagonists, such as naloxone, to reduce drugrelated mortality; 27. Invites Member States to promote cooperation with and technical assistance to the States most affected by the transit of drugs in developing and implementing comprehensive and integrated policies to address, where appropriate, the impact of illicit drug trafficking on increasing drug use in such States, including by reinforcing national programmes aimed at prevention, early intervention, treatment, care, rehabilitation and social reintegration; 28. Encourages the United Nations Office on Drugs and Crime and the International Narcotics Control Board to continue to strengthen cooperation with the World Health Organization and other competent United Nations entities, within their respective mandates, as part of a comprehensive, integrated and balanced approach to strengthening health and social welfare measures in addressing the world drug problem, including through effective prevention, early intervention, treatment, care, recovery, rehabilitation and social reintegration, in cooperation, as appropriate, with civil society and the scientific community, and to keep the Commission on Narcotic Drugs appropriately updated; 29. Recalls the signing of the memorandum of understanding between the United Nations Office on Drugs and Crime and the World Health Organization in February 2017, which will facilitate increased collaboration and coordination between these two entities, within their mandates, in advancing efforts to address and counter the world drug problem, and encourages the Office to continue to strengthen its collaboration with the World Health Organization and to explore, as appropriate, cooperation arrangements with other relevant United Nations agencies and entities and to keep the Commission on Narcotic Drugs appropriately updated; 30. Encourages the United Nations Office on Drugs and Crime and the World Health Organization to continue their collaboration to address and counter the world drug problem in accordance with their relevant mandates, and takes note of the input of the World Health Organization in addressing and countering the world drug problem from a public health dimension; 31. Encourages Member States to involve, as appropriate, policymakers, parliamentarians, educators, civil society, the scientific community, academia, target populations, individuals in recovery from substance use disorders and their peer groups, families and other co-dependent people, as well as the private sector, in the development of prevention programmes aimed at raising public awareness of the dangers and risks associated with drug abuse, and involve, inter alia, parents, care services providers, teachers, peer groups, health professionals, religious communities, community leaders, social workers, sports associations, media professionals and entertainment industries, as appropriate, in their implementation; 32. Also encourages Member States to consider alternatives to incarceration, conviction and punishment, where appropriate and in accordance with the three international drug control conventions, noting that, in appropriate cases of a minor nature, States may provide, as alternatives to conviction or punishment, measures 18-22288 9/22